CDK2 and neoplasm: For instance, researchers identified that homoharringtonine (HHT) could bind to the PPI site of CDK2, disrupting the interaction between CDK2 and cyclin A, resulting in a loss of CDK2 activity and protein degradation, and preventing tumor progression 37.